A backend the marketing team uses without calling a developer.
Pharmaceutical CMS implementation for companies whose content passes medical and regulatory review: a backend where the local team can publish freely inside a structure that was approved, and cannot accidentally break outside it.
The failure mode is predictable. The CMS is either so locked down that every change needs a developer, or so open that within a year the site has forty layouts and no consistency. Neither survives a regulated review cycle, and both end with the marketing team back on email.
Content modelling, a component-based editing experience, roles and publishing permissions, multilingual and market handling, and training for the people who will actually use it.
We build the CMS your editorial process runs inside, leaving the process itself and content approval with the team who already owns it.
The content volumes behind our pharmaceutical CMS implementation work.
A two-person marketing team and a network of affiliates need opposite things. Pharmaceutical CMS implementation starts from who will use it.
What companies ask before committing to a platform.
Usually WordPress built as a structured system, because for most pharmaceutical companies it covers the requirement at a fraction of the licence and implementation cost of an enterprise platform. Where a group has already standardised on something else, we work within that rather than arguing for a change no one asked for.
Yes, and preventing that is one of the main reasons to implement properly rather than installing a generic page builder. Component-based editing means editors choose from a defined set of blocks with defined fields, so the design stays coherent regardless of who on the team is publishing that day.
Yes, and the decision to make early is which fields are shared and which are translated. Technical data should exist once and render everywhere; only the copy layer should vary. Getting that wrong is what causes language versions to drift apart.
Then the first question is whether the platform itself is the problem, or whether the implementation of it is. Frequently a perfectly capable CMS was simply set up badly at the start, and restructuring the content model inside it costs far less time and budget than ripping it out and replacing it.
CMS work usually arrives as part of a build, a migration or a redesign. These are the services it sits with.
A backend nobody wants to open, or a new platform that has to work for a small team. Tell us who edits the site and we will tell you how we would approach the pharmaceutical CMS implementation.